Literature DB >> 24380860

Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells.

Heike Bähre1, Kerstin Y Danker2, Johannes-Peter Stasch3, Volkhard Kaever4, Roland Seifert5.   

Abstract

Soluble guanylyl cyclase (sGC) is activated by nitric oxide (NO) and generates the second messenger cyclic GMP (cGMP). Recently, purified sGC α1β1 has been shown to additionally generate the cyclic pyrimidine nucleotides cCMP and cUMP. However, since cyclic pyrimidine nucleotide formation occurred only the presence of Mn(2+) but not Mg(2+), the physiological relevance of these in vitro findings remained unclear. Therefore, we studied cyclic nucleotide formation in intact cells. We observed NO-dependent cCMP- and cUMP formation in intact HEK293 cells overexpressing sGC α1β1 and in RFL-6 rat fibroblasts endogenously expressing sGC, using HPLC-tandem mass spectrometry. The identity of cCMP and cUMP was unambiguously confirmed by HPLC-time-of-flight mass spectrometry. Our data indicate that cCMP and cUMP play second messenger roles and that Mn(2+) is a physiological sGC cofactor.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cyclic CMP; Cyclic GMP; Cyclic UMP; Manganese; Nitric oxide; Soluble guanylyl cyclase

Mesh:

Substances:

Year:  2013        PMID: 24380860     DOI: 10.1016/j.bbrc.2013.12.108

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  cCMP and cUMP occur in vivo.

Authors:  Heike Bähre; Christina Hartwig; Antje Munder; Sabine Wolter; Tane Stelzer; Bastian Schirmer; Ulrike Beckert; Dara W Frank; Burkhard Tümmler; Volkhard Kaever; Roland Seifert
Journal:  Biochem Biophys Res Commun       Date:  2015-03-31       Impact factor: 3.575

2.  Is cIMP a second messenger with functions opposite to those of cGMP?

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-15       Impact factor: 3.000

3.  Tissues cIMPly do not lie.

Authors:  Yuansheng Gao; Paul M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-23       Impact factor: 3.000

4.  TRPV4, TRPC1, and TRPP2 assemble to form a flow-sensitive heteromeric channel.

Authors:  Juan Du; Xin Ma; Bing Shen; Yu Huang; Lutz Birnbaumer; Xiaoqiang Yao
Journal:  FASEB J       Date:  2014-08-11       Impact factor: 5.191

5.  cUMP hydrolysis by PDE3A.

Authors:  Stefan Berrisch; Jessica Ostermeyer; Volkhard Kaever; Solveig Kälble; Denise Hilfiker-Kleiner; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

6.  cUMP hydrolysis by PDE3B.

Authors:  Jessica Ostermeyer; Franziska Golly; Volkhard Kaever; Stefan Dove; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

Review 7.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

8.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

9.  Hydrolysis of the non-canonical cyclic nucleotide cUMP by PDE9A: kinetics and binding mode.

Authors:  Jessica Scharrenbroich; Volkhard Kaever; Stefan Dove; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-15       Impact factor: 3.000

10.  cCMP is a substrate for MRP5.

Authors:  Svenja Laue; Moritz Winterhoff; Volkhard Kaever; Jeroen J van den Heuvel; Frans G Russel; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.